FOLFOX-HAIC versus first-line systemic chemotherapy in HBsAg-positive patients with unresectable intrahepatic cholangiocarcinoma: A propensity score matched cohort study
{{output}}
Background: The optimal treatment strategy for hepatitis B surface antigen (HBsAg)-positive patients with unresectable intrahepatic cholangiocarcinoma (ICC) remains unclear. This study aimed to compare the efficacy and safety of ... ...
